At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

Please find enclosed copy of the Unaudited Financial Results for the quarter and nine months ended 30th September 2024.

Novavax Inc (NVAX) reports increased product sales and a strong cash position, while revising revenue guidance and navigating ...